Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - LIT


VANCOUVER, BC, Sept. 27, 2023 /CNW/ - Trading resumes in:

Company: Argentina Lithium & Energy Corp.

TSX-Venture Symbol: LIT

All Issues: No

Resumption (ET): 2:15 PM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 14:15
A hearing has been scheduled before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Investment Dealer and Partially Consolidated Rules to set a date for a disciplinary hearing in the matter of James O'Reilly....

at 14:15
Pomerantz LLP is investigating claims on behalf of investors of Integral Ad Science Holding Corp. ("IAS" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 14:14
USA News Group ? Even though prices are currently down from where they were in 2022, experts still see the monumental importance of lithium in the years and decades ahead. According to a recent post, the UN Trade & Development (UNCTAD) projects based...

at 14:05
Sprott Inc. ("Sprott" or the "Company") announced today that its Board of Directors has declared a first quarter 2024 dividend of US$0.25 per common share, payable on June 5, 2024 to shareholders of record at the close of business on May 21, 2024....

at 14:02
Sharp Token, the highly anticipated "Learn2Earn" and "Spend2Grow" utility token officially launches May 7th on the Coinstore exchange. The Sharp Token is a utility reward token focused on tech education, learning, and community member growth....

at 14:02
BeiGene Canada, the country affiliate of global oncology company BeiGene, specializing in the discovery and development of novel, affordable, and accessible oncology medications, has opened its first office in Canada. Situated in downtown Toronto,...



News published on and distributed by: